stars 1 stars 2 stars 3

About PARADIGM Paradigm is a molecular information corporation established to bring cutting-edge diagnostics to cancer patients and industry by providing information about the genomic makeup of the patient’s cancer and potential therapies based on the specific characterization of the patient’s tumor that can impact the patient’s course of treatment. Paradigm’s Next-Generation Sequencing based diagnostic test PCDx provides oncologists and patients with more precise information about the specific cancer pathways in the patient and associations between the pathways and the specific drugs available that can affect the cancer to allow for more effective decision-making. The test is driven by supporting data and literature and provides more choices for patient care than currently available on the market. For more information visit http://www.paradigmdx.com or visit us on Twitter @Paradigm_DX

Paradigm Diagnostics Questions

The Paradigm Diagnostics annual revenue was $4 million in 2026.

Stuart Bunt is the Owner of Paradigm Diagnostics.

1 people are employed at Paradigm Diagnostics.

Paradigm Diagnostics is based in Phoenix, Arizona.

The NAICS codes for Paradigm Diagnostics are [621111, 54171, 6211, 621, 62111, 541, 62, 54, 541711, 5417].

The SIC codes for Paradigm Diagnostics are [801, 80].

Top Paradigm Diagnostics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users